Cognitive Reappraisal Training for Borderline Personality
Public ClinicalTrials.gov record NCT04967222. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Cognitive Reappraisal Training Targeting Emotion Circuits As a Therapeutic Intervention in Borderline Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Previous work by the study group convinced the study team to pursue development of focused cognitive reappraisal training as a novel approach to treatment of BPD, either as stand-alone treatment or in concert with evidence-based treatments of BPD. The present proposal aims to refine and test a proposed clinical intervention for BPD patients, training in reappraisal-by-distancing, in terms of its ability to influence hypothesized neural and behavioral targets and, once that is established, to demonstrate its ability improve clinically relevant outcome measures.
Study identification
- NCT ID
- NCT04967222
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- Cognitive Reappraisal by Distancing Behavioral
- Control Downregulate Condition Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2021
- Primary completion
- Jun 2, 2024
- Completion
- Jun 2, 2024
- Last update posted
- Aug 4, 2025
2021 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | New York | New York | 10024 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Borderline Personality Disorder trials
Other public records listing Borderline Personality Disorder. Sorted by last update posted; newest first. Not a recommendation.
- NCT05800925: Triage Survey for Psychiatry Research Eligibility Recruiting
- NCT05651295: A Precision Medicine Approach to Target Engagement for Emotion Regulation Recruiting
- NCT05712057: Neurostimulation Versus Therapy for Problems With Emotions Recruiting
- NCT07223619: PILOT Phase: BPD Study Active, not recruiting
- NCT06683014: MDMA in Borderline Personality Disorder Recruiting
- NCT06005129: Personality Change Study for Borderline Personality Disorder Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04967222, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2025 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04967222 live on ClinicalTrials.gov.